BMP2–ERK–ATF4 Axis-Based 6-methoxybenzofuran Compound I-9 Acts as Candidate Drug for Bone Formation and Anti-Osteoporosis
Ziying Zhou(Ningxia Medical University), Zhuorong Li(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 5
Related Papers
Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression
|Metabolism|2008|265
Hawthorn with “homology of medicine and food”: a review of anticancer effects and mechanisms
|Frontiers in Pharmacology|2024|12
<p>Synthesis and Bioactivity of <em>N</em>-(4-Chlorophenyl)-4-Methoxy-3-(Methylamino) Benzamide as a Potential Anti-HBV Agent</p>
|Drug Design Development and Therapy|2020|5